JPY 653.0
(-1.51%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - JPY | 0.0% |
2022 | - JPY | 0.0% |
2021 | - JPY | 0.0% |
2020 | - JPY | 0.0% |
2019 | - JPY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - JPY | 0.0% |
2023 Q4 | - JPY | 0.0% |
2023 Q3 | - JPY | 0.0% |
2023 Q2 | - JPY | 0.0% |
2023 Q1 | - JPY | 0.0% |
2023 FY | - JPY | 0.0% |
2022 Q3 | - JPY | 0.0% |
2022 Q2 | - JPY | 0.0% |
2022 Q4 | - JPY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 18.14 Billion JPY | 100.0% |
Cosmo Bio Company,Limited | - JPY | NaN% |
H.U. Group Holdings, Inc. | 60.1 Billion JPY | 100.0% |
FALCO HOLDINGS Co., Ltd. | 148 Million JPY | 100.0% |
BML, Inc. | 3.73 Billion JPY | 100.0% |
Human Metabolome Technologies, Inc. | 11.34 Million JPY | 100.0% |
Precision System Science Co., Ltd. | 289.67 Million JPY | 100.0% |